Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of DS-6051b in solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DS-6051b

Snippet

Sponsor: Nuvation Bio Inc. | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED